medicalcondition:stomach cancer

UK scientists test breathalyser for detecting early #cancers | Society | The Guardian
▻https://www.theguardian.com/society/2019/jan/03/uk-scientists-test-breathalyser-for-detecting-early-cancers

https://i.guim.co.uk/img/media/8f69eb4c8ac52f3fbd7996f4e4d14a789b3417f6/87_432_864_519/master/864.jpg?width=1200&height=630&quality=85&auto=format&fit=crop&overlay-align=bottom%2Cleft&overlay-width=100p&overlay-base64=L2ltZy9zdGF0aWMvb3ZlcmxheXMvdGctZGVmYXVsdC5wbmc&s=63055b0ce0e3b01712dad193ed77fce0

A breathalyser test that could revolutionise cancer diagnosis is being tested in the UK. The Breath Biopsy device is designed to detect cancer hallmarks in molecules exhaled by patients.

Scientists hope it will lead to a simpler, cheaper method of spotting cancers early. The breathalyser has the potential to save thousands of lives and millions of pounds in healthcare costs, its developers have claimed.

The two-year trial, taking place at Addenbrooke’s hospital in Cambridge, is recruiting 1,500 participants, including healthy individuals as well as cancer patients.

Initially, patients with suspected oesophageal and stomach cancers will be asked to try the test. Later it will be extended to include prostate, kidney, bladder, liver and pancreatic cancers.

#santé #dépistage

There Is No ‘Healthy’ #Microbiome
▻http://www.nytimes.com/2014/11/02/opinion/sunday/there-is-no-healthy-microbiome.html

It may be that a Hadza microbiome would work equally well in an American gut, but incompatibilities are also possible. The conquistadors proved as much. As they colonized South America, they brought with them European strains of Helicobacter pylori, a stomach bacterium that infrequently causes ulcers and stomach cancer, and these European strains also displaced native American ones. This legacy persists in Colombia, where some communities face a 25-fold higher risk of stomach cancer, most likely due to mismatches between their ancestral genomes and their H. pylori strains.

Rapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010 : The Lancet
▻http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(13)61097-1/fulltext?_eventId=login

...levels of premature mortality in China relative to other members of the G20 in 2010.

For men in China in 2010, age-standardised rates of years of life lost due to ischaemic heart disease, lower respiratory infections, cirrhosis, diabetes, preterm birth complications, chronic kidney diseases, HIV/AIDS, and tuberculosis were significantly better than the G20 mean. China had significantly worse ranks than the mean for stroke, chronic obstructive pulmonary disease, liver cancer, stomach cancer, oesophageal cancer, leukaemia, drowning, and falls. The YLL rates of road injury and lung cancer for 2010 are indistinguishable from the mean but the absolute increase in YLLs from these causes is concerning. For women in China, we noted better than G20 average performance on ischaemic heart disease, lower respiratory infections, diabetes, breast cancer, preterm birth complications, chronic kidney diseases, cervical cancer, cirrhosis, and cardiovascular and circulatory diseases. We noted worse than G20 average outcomes for stroke, chronic obstructive pulmonary disease, road injury, self-harm, liver cancer, stomach cancer, oesophageal cancer, falls, drowning, and rheumatic heart disease.

Even for conditions such as ischaemic heart disease, lung cancer, and diabetes (for which China was better than average in the G20 in 2010), rising rates suggest that this status might change in the near future.

http://download.thelancet.com/images/journalimages/0140-6736/PIIS0140673613610971.gr4.lrg.jpg